| Literature DB >> 33868440 |
Yongliang Jiang1, Hantong Hu1,2, Xiaoyu Li1, Jiali Lou1, Yajun Zhang1, Xiaofen He1, Yuanyuan Wu1, Xiaomei Shao1, Jianqiao Fang1.
Abstract
OBJECTIVE: By comparing the differences in microcirculatory responses of the heart and lung meridians induced by moxibustion on these two meridians, respectively, this study aimed to investigate the specificity for site-to-site association on body surface between different meridians.Entities:
Year: 2021 PMID: 33868440 PMCID: PMC8032512 DOI: 10.1155/2021/6644625
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Moxibustion site and LDF measurement sites of the heart and lung meridians. (a) Moxibustion site and LDF measurement sites in the lung meridian intervention group. (b) Moxibustion site and LDF measurement sites in the heart meridian intervention group.
Anatomical location of acupoints and LDF measurement sites of the heart and lung meridians.
| Acupoints and LDF measurement sites | Anatomical location |
|---|---|
| “Shenmen” (HT7) | On the anteromedial aspect of the wrist, radial to the flexor carpi ulnaris tendon, on the palmar wrist crease. |
| “Taiyuan” (LU9) | On the anterolateral aspect of the wrist, between the radial styloid process and the scaphoid bone, in the depression ulnar to the abductor pollicis longus tendon. |
| “Chize” (LU5) | On the anterior aspect of the elbow, at the cubital crease, in the depression lateral to the biceps brachii tendon. |
| “Shaohai” (HT3) | On the anteromedial aspect of the elbow, just anterior to the medial epicondyle of the humerus, at the same level as the cubital crease. |
| The midpoint of the lung meridian along the forearm | The midpoint between LU5 and LU9 |
| The midpoint of the heart meridian along the forearm | The midpoint between HT3 and HT7 |
Figure 2LDF measurement procedure. LDF: laser Doppler flowmetry.
Fundamental physiological parameters of the study subjects prior to and immediately after LDF examination in both groups (mean ± standard deviation).
| Physiological parameters | Lung meridian intervention group | Heart meridian intervention group | ||
|---|---|---|---|---|
| Prior to LDF examination | Immediately after LDF examination | Prior to LDF examination | Immediately after LDF examination | |
| SBP (mmHg) | 115.65 ± 4.29 | 114.32 ± 4.37 | 110.98 ± 5.87 | 109.25 ± 8.87 |
| DBP (mmHg) | 76.75 ± 5.13 | 75.05 ± 4.30 | 70.13 ± 5.20 | 69.85 ± 6.58 |
| HR (bpm) | 77.45 ± 4.77 | 76.53 ± 4.57 | 71.05 ± 6.28 | 70.01 ± 6.52 |
| Body temperature (°C) | 36.59 ± 0.15 | 36.56 ± 0.14 | 36.44 ± 0.10 | 36.40 ± 0.16 |
SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; bpm: beats per minute.
Figure 3Changes of blood perfusion in three sites during different phases in the lung meridian intervention group. (i) Data are presented as mean ± SEM; (ii) “Pre” means 5 min premoxibustion phase, “A” means moxibustion phase A, “B” means moxibustion phase B, “C” means moxibustion phase C, “Post” means 5 min postmoxibustion phase; (iii) p < 0.001 and p < 0.01 when compared with premoxibustion PU.
Blood perfusion and its corresponding change magnitude in both meridians in the lung meridian intervention group (mean ± SEM, PU).
| Premoxibustion phase | During 15 min moxibustion | 5 min postmoxibustion phase | |||
|---|---|---|---|---|---|
| Phase A | Phase B | Phase C | |||
| The midpoint between LU5 and LU9 | 8.54 ± 0.44 | 9.37 ± 0.47 | 9.98 ± 0.50 | 10.35 ± 0.52 | 10.33 ± 0.53 |
| — | (0.83 ± 0.15)††## | (1.44 ± 0.21)††## | (1.81 ± 0.27)††## | (1.78 ± 0.28)††## | |
| The midpoint between HT3 and HT7 | 9.68 ± 0.56 | 8.91 ± 0.52 | 8.95 ± 0.52 | 8.59 ± 0.49 | 8.34 ± 0.47 |
| — | (−0.77 ± 0.20) | (−0.73 ± 0.18) | (−1.09 ± 0.25) | (−1.34 ± 0.24) | |
| HT3 of the heart meridian | 7.62 ± 0.47 | 7.30 ± 0.46 | 7.28 ± 0.45 | 7.21 ± 0.46 | 7.18 ± 0.45 |
| — | (−0.31 ± 0.14) | (−0.33 ± 0.16) | (−0.40 ± 0.18) | (−0.44 ± 0.19) | |
(i) PU: perfusion units. The values in parentheses were the increase (or decrease) values of PU compared with premoxibustion; (ii) p < 0.001 and p < 0.01, compared with premoxibustion PU; (iii) ††p < 0.001, compared with the midpoint between HT3 and HT7; ##p < 0.001, compared with HT3.
Figure 4Changes of blood perfusion in three sites during different phases in the heart meridian intervention group. (i) Data are presented as mean ± SEM; (ii) “Pre” means 5 min premoxibustion phase, “A” means moxibustion phase A, “B” means moxibustion phase B, “C” means moxibustion phase C, “Post” means 5 min postmoxibustion phase; (iii) p < 0.001 and p < 0.01 when compared with premoxibustion PU.
Blood perfusion and its corresponding change magnitude in measurement sites of both meridians in the heart meridian intervention group (mean ± SEM, PU).
| Premoxibustion phase | During 15 min moxibustion | 5 min postmoxibustion phase | |||
|---|---|---|---|---|---|
| Phase A | Phase B | Phase C | |||
| The midpoint between HT3 and HT7 | 8.39 ± 0.28 | 8.95 ± 0.33 | 9.24 ± 0.36 | 9.31 ± 0.33 | 9.11 ± 0.33 |
| — | (0.56 ± 0.15)††## | (0.85 ± 0.16)††## | (0.92 ± 0.16)††## | (0.71 ± 0.17)††## | |
| LU5 of the lung meridian | 10.49 ± 0.39 | 10.37 ± 0.39 | 10.30 ± 0.41 | 10.31 ± 0.40 | 10.33 ± 0.39 |
| — | (−0.12 ± 0.04) | (−0.19 ± 0.07) | (−0.18 ± 0.07) | (−0.16 ± 0.04) | |
| The midpoint between LU5 and LU9 | 9.20 ± 0.32 | 8.89 ± 0.29 | 8.88 ± 0.31 | 8.82 ± 0.30 | 8.80 ± 0.33 |
| — | (−0.31 ± 0.08) | (−0.32 ± 0.09) | (−0.39 ± 0.09) | (−0.41 ± 0.07) | |
(i) PU: perfusion units. The values in parentheses were the increase (or decrease) values of PU compared to premoxibustion; (ii) p < 0.001 and p < 0.01, compared with premoxibustion PU; (iii) ††p < 0.001, compared with LU5; ##p < 0.001, compared with the midpoint between LU5 and LU9.